A detailed history of Swedbank Ab transactions in Abb Vie Inc. stock. As of the latest transaction made, Swedbank Ab holds 2,147,126 shares of ABBV stock, worth $376 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
2,147,126
Previous 2,140,316 0.32%
Holding current value
$376 Million
Previous $367 Million 15.5%
% of portfolio
0.55%
Previous 0.5%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$163.84 - $199.33 $1.12 Million - $1.36 Million
6,810 Added 0.32%
2,147,126 $424 Million
Q2 2024

Jul 18, 2024

BUY
$154.79 - $180.76 $331 Million - $387 Million
2,140,316 New
2,140,316 $367 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $322 Million - $367 Million
2,017,416 New
2,017,416 $367 Million
Q4 2023

Dec 09, 2024

BUY
$137.6 - $154.97 $3.83 Million - $4.31 Million
27,810 Added 1.51%
1,864,496 $289 Million
Q3 2023

Dec 09, 2024

BUY
$133.59 - $154.65 $7.75 Million - $8.98 Million
58,039 Added 3.26%
1,836,686 $274 Million
Q2 2023

Dec 09, 2024

BUY
$132.51 - $164.9 $10.9 Million - $13.5 Million
82,144 Added 4.84%
1,778,647 $240 Million
Q1 2023

Dec 09, 2024

BUY
$144.61 - $166.54 $8.27 Million - $9.53 Million
57,199 Added 3.49%
1,696,503 $270 Million
Q4 2022

Dec 09, 2024

BUY
$138.31 - $165.87 $7.22 Million - $8.65 Million
52,177 Added 3.29%
1,639,304 $265 Million
Q3 2022

Dec 09, 2024

BUY
$134.21 - $153.93 $35.7 Million - $40.9 Million
265,897 Added 20.12%
1,587,127 $213 Million
Q2 2022

Dec 09, 2024

BUY
$137.62 - $174.96 $25.7 Million - $32.7 Million
186,615 Added 16.45%
1,321,230 $202 Million
Q1 2022

Dec 09, 2024

BUY
$131.98 - $163.75 $2.39 Million - $2.97 Million
18,133 Added 1.62%
1,134,615 $184 Million
Q4 2021

Dec 09, 2024

BUY
$107.43 - $135.93 $3.86 Million - $4.89 Million
35,964 Added 3.33%
1,116,482 $151 Million
Q3 2021

Dec 09, 2024

BUY
$106.4 - $120.78 $11 Million - $12.5 Million
103,794 Added 10.63%
1,080,518 $117 Million
Q2 2021

Dec 09, 2024

BUY
$105.21 - $117.21 $7.54 Million - $8.4 Million
71,653 Added 7.92%
976,724 $110 Million
Q1 2021

Dec 09, 2024

BUY
$102.3 - $112.62 $92.6 Million - $102 Million
905,071 New
905,071 $97.9 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Swedbank Ab Portfolio

Follow Swedbank Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

News

Stay updated on Swedbank Ab with notifications on news.